{"title":"消融后的新鳞状上皮在基因组上易发生恶性进展吗?","authors":"Emily L Black, Rebecca C Fitzgerald","doi":"10.1136/bmjonc-2023-000183","DOIUrl":null,"url":null,"abstract":"Radiofrequency ablation (RFA) is a frequently used treatment for dysplastic Barrett’s oesophagus or early oesophageal intramucosal carcinomas.[1 2][1] As a treatment, it is widely considered to be safe and effective at removing these aberrant lesions. The treated areas are re-populated with","PeriodicalId":72436,"journal":{"name":"BMJ oncology","volume":"2011 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Is post-ablation neo-squamous epithelium genomically predisposed to malignant progression?\",\"authors\":\"Emily L Black, Rebecca C Fitzgerald\",\"doi\":\"10.1136/bmjonc-2023-000183\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Radiofrequency ablation (RFA) is a frequently used treatment for dysplastic Barrett’s oesophagus or early oesophageal intramucosal carcinomas.[1 2][1] As a treatment, it is widely considered to be safe and effective at removing these aberrant lesions. The treated areas are re-populated with\",\"PeriodicalId\":72436,\"journal\":{\"name\":\"BMJ oncology\",\"volume\":\"2011 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjonc-2023-000183\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjonc-2023-000183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Is post-ablation neo-squamous epithelium genomically predisposed to malignant progression?
Radiofrequency ablation (RFA) is a frequently used treatment for dysplastic Barrett’s oesophagus or early oesophageal intramucosal carcinomas.[1 2][1] As a treatment, it is widely considered to be safe and effective at removing these aberrant lesions. The treated areas are re-populated with
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
